SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-12-008691
Filing Date
2012-08-17
Accepted
2012-08-17 19:51:13
Documents
1
Period of Report
2012-08-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rdgdoc.html 4  
1 PRIMARY DOCUMENT rdgdoc.xml 4 6391
  Complete submission text file 0001437749-12-008691.txt   7750
Mailing Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2
Business Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2 604-456-6010
RESPONSE BIOMEDICAL CORP (Issuer) CIK: 0000806888 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 8734 Services-Testing Laboratories

Mailing Address C/O RESPONSE BIOMEDICAL CORP 1781-75TH AVENUE W. VANCOUVER A1 V6P 6P2
Business Address
PURVIN JEFFREY L (Reporting) CIK: 0001227578 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50571 | Film No.: 121043738